Ensoma is expanding the reach of the curative power of genomic medicine by pioneering a next-generation in vivo approach using its Engenious™ vectors. Ensoma’s vectors are designed to deliver a diverse range of gene modification technologies without the need for stem cell collection or prior myeloablative conditioning (e.g. chemotherapy). Learn more at www.ensoma.com.
Location: United States, Massachusetts, Boston
Total raised: $205M
Investors 6
Date | Name | Website |
12.02.2021 | 5AM Ventur... | 5amventure... |
06.02.2022 | Takeda Ven... | takeda.com |
- | F-Prime Ca... | fprimecapi... |
- | Catalio Ca... | cataliocap... |
31.01.2023 | Solasta Ve... | solasta-ve... |
- | SymBiosis | symbiosis.... |
Funding Rounds 3
Date | Series | Amount | Investors |
16.05.2023 | Series B | $50M | Delos Capi... |
10.01.2023 | Series B | $85M | - |
11.02.2021 | - | $70M | - |
Mentions in press and media 5
Date | Title | Description | Source |
16.05.2023 | Ensoma Closes $50M Series B Extension; Brings Total Round to... | Ensoma, a Boston, MA-based genomic medicines company developing one-time, in vivo treatments that pr... | finsmes.co... |
10.01.2023 | Ensoma Raises $85M in Series B Funding; Acquires Twelve Bio | Ensoma, a Boston, MA-based genomic medicines company developing one-time in vivo treatments that pre... | finsmes.co... |
12.02.2021 | Daily funding roundup - February 11th, 2021 | Zocdoc raised $150M; Modern Health landed $74M; Human Interest secured $55M; WireWheel picks up $20M... | vator.tv/n... |
11.02.2021 | Fred Hutch, Univ. of Washington biotech spinout Ensoma launc... | Dr. Hans-Peter Kiem of the Fred Hutchinson Cancer Research Center. (Fred Hutch Photo) New spinout: ... | geekwire.c... |
- | Ensoma | “Ensoma – The future of medicine lies within us.” | fastfounde... |